Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial

1. Campone, M.
2. De Laurentiis, M.
3. Zamagni, C.
4. Kudryavcev, I.
5. Agterof, M.
6. Brown-Glaberman, U.
7. Palácová, M.
8. Chatterjee, S.
9. Menon-Singh, L.
10. Wu, J.
11. Martín, M.